Professor Christopher Hawkey

Professor Christopher Hawkey

Professor of Gastroenterology

+44 115 823 1033 View full bio
Queens Medical Centre Campus, Derby Road, Nottingham, NG7 2UH

Christopher Hawkey is Professor of Gastroenterology at the Nottingham Digestive Diseases Centre. His main interests are in the field of non-steroid anti-inflammatory drugs and inflammatory bowel disease. In both areas his approach is to try to identify targets in small exploratory studies and then evaluate them in large and/or outcomes studies.

Research Summary

Interests

  • Non-steroidal anti-inflammatory drugs
  • Inflammatory bowel disease
  • Chemoprophylaxis of gastrointestinal cancers

Techniques

  • Clinical trials including: Phase I assessments, particularly by endoscopy in volunteers Small proof of concept Phase II trials Clinical trial design, including Outcome studies
  • Ex-vivo translational research
  • Current research projects
  • Target Outcomes Study of selective vs non-selective NSAIDs
Publications
Title
Gastroduodenal toxicity of low-dose acetylsalicylic acid: a comparison with non-steroidal anti-infla
Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of c
Clinical trial: a randomized trial of early endoscopy, Helicobacter pylori testing and empirical the
Beliefs about personal control and self-management in 30-40 year olds living with Inflammatory Bowel
Comparison of High Definition with Standard White Light Endoscopy for Detection of Dysplastic Lesion
Predictors of gastroduodenal erosions in patients taking low-dose aspirin
A Novel Composite Endpoint to Evaluate the Gastrointestinal Effects of NSAID Through the Entire GI T
Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ul
Drugs that cause and heal peptic ulcer disease
Guest authorship, mortality reporting, and integrity in rofecoxib studies
NSAIDs and aspirin: notorious or FAMOUS?
Rofecoxib and Clinically Significant Gastrointestinal Events
Safer NSAID strategies: consensus or contentious?
Autologous stem cell transplantation for Crohn’s disease (ASTIC) Trial:  Early report of toxicity an
Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazole
Clinical trial: comparison of the gastrointestinal safety of lumiracoxib with traditional nonselecti
Esomeprazole for the Management of Upper Gastrointestinal Symptoms in Patients Who Require NSAIDs A
Clinical and endoscopic improvement following haemopoietic stem cell transplantation on behalf of th
Optical Microangiography: High-Definition Magnification Colonoscopy with Narrow Band Imaging (NBI) f
Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplas
Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colo
Feasibility of reducing aspirin-associated ulcer bleeding by Helicobacter pylori eradication
Efficacy of New Playback Functions at Reducing Small-Bowel Wireless Capsule Endoscopy Reading Times